Donenberg Phillip B.
CIK 0001238120
Director
Filings
13
Latest Jun 2, 2026
Issuers covered
3
Showing
13 of 13
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +22.6% | +22.6% | +70.5% | -25.3% |
| 90 days | 2 | 0% | -37.5% | -37.5% | -31.1% | -44.0% |
| 180 days | 2 | 0% | -29.5% | -29.5% | -12.4% | -46.5% |
| 365 days | 2 | 50% | -33.0% | -33.0% | +18.7% | -84.6% |
Issuers
Companies where Donenberg Phillip B. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | 7 | Jun 2, 2026 |
| AVRO | Avrobio, Inc. | 4 | Jun 11, 2025 |
| SNSE | Sensei Biotherapeutics, Inc. | 2 | Apr 14, 2026 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|